Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01854957

MEsenchymal StEm Cells for Multiple Sclerosis (MESEMS)

MEsenchymal StEm Cells for Multiple Sclerosis (MESEMS) Phase I-II Clinical Trial With Autologous Mesenchymal Stem Cells (MSCs) for the Therapy of Multiple Sclerosis

Sponsor: Antonio Uccelli

Conditions Multiple Sclerosis

Interventions Autologous Mesenchymal Stem Cells

Updated 5 times since 2017 Last updated: May 13, 2013 Started: Jul 31, 2012 Primary completion: Jul 31, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Multiple Sclerosis and is currently ongoing. Antonio Uccelli leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Antonio Uccelli
Azienda Ospedaliera Universitaria Integrata Verona
Ospedale San Raffaele

Data source: University of Genova

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Genova, Italy